Charles River Laboratories International, Inc. (CRL) is scheduled to report third-quarter 2024 results on Nov. 6, before market open.In the last reported quarter, the company’s adjusted earnings per share of $2.80 surpassed the Zacks Consensus Estimate by 17.2%. Earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 11.64%.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.CRL’s Q3 EstimatesThe Zacks Consensus Estimate for revenues is pegged ...